RCAP
AURA icon

Resolute Capital Asset Partners’s Aura Biosciences AURA Stock Holding History

Resolute Capital Asset Partners’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-91,006
Closed -$496K – 44
2025
Q4 		$496K Hold
91,006
– – 0.24% 43
2025
Q3 		$562K Hold
91,006
– – 0.29% 44
2025
Q2 		$570K Buy
+91,006
New +$532K 0.3% 42

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Resolute Capital Asset Partners's AURA Position: Q1 2026 in Review

Resolute Capital Asset Partners sold out of Aura Biosciences (AURA) in Q1 2026, closing a stake of 91,006 shares — an estimated $496K sold.

Resolute Capital Asset Partners first reported a position in AURA in Q2 2025 and held it in 3 quarters. The position peaked at $570K in Q2 2025. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Resolute Capital Asset Partners reported no remaining Aura Biosciences position as of Q1 2026 after selling out during the quarter.
  • Resolute Capital Asset Partners sold 91,006 Aura Biosciences shares in Q1 2026, an estimated $496K.
  • Resolute Capital Asset Partners first reported a position in Aura Biosciences in Q2 2025 and held it in 3 quarters.
  • Resolute Capital Asset Partners's Aura Biosciences position peaked at $570K in Q2 2025.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Resolute Capital Asset Partners's 13F filing for Q1 2026, filed 15 May 2026.